Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/04/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/11/23 | Current report filing |
|
 |
6 | |
| 11/14/23 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
50 | |
| 11/14/23 | Current report filing |
|
|
8 | |
| 10/24/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 10/17/23 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
3 | ||
| 10/13/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 10/12/23 | Statement of changes in beneficial ownership of securities |
|
1 |